Abstract
A few recent individual case reports have suggested that a myasthenic syndrome may be associated with statin treatment, but this association is not well described. We report 4 patients who developed symptoms of myasthenia gravis within 2 weeks of starting treatment with a statin drug. In 1 case the drug appears to have exacerbated underlying myasthenic weakness, whereas in the other 3 cases, de novo antibody formation appears to be most likely. In each case, some degree of recovery followed discontinuation of the statin medication.
Original language | English |
---|---|
Pages (from-to) | 82-85 |
Number of pages | 4 |
Journal | Medicine |
Volume | 85 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2006 |
Externally published | Yes |